The interaction between BCI (H/I) and extended endocrine treatment was statistically significant for RFI (P = 0.01), DFI (P = 0.01), and DFS (P < 0.01), when corrected for age, tumor size, grade, ER, and PR status. The gene discussed is PGR; the disease is neoplasm.